JANX - Janux Therapeutics, Inc.

QQQ $ 433.27 $ 0.14 (0.03 %)

DIA $ 383.51 $ 0.24 (0.06 %)

SPY $ 510.45 $ 0.16 (0.03 %)

TLT $ 88.63 $ -0.03 (-0.03 %)

GLD $ 215.96 $ -0.09 (-0.04 %)

Previous Close

$ 47.39

Open

$ 47.97

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 47.97 - $ 49.63

52 Week Range

$ 5.65 - $ 58.69

Volume

573,989

Average Volume

Market Cap

2.09B

Beta (5Y Monthly)

$ 2.14

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-08-2024	12-31-2023	10-K
2	11-07-2023	09-30-2023	10-Q
3	08-08-2023	06-30-2023	10-Q
4	05-09-2023	03-31-2023	10-Q
5	03-10-2023	12-31-2022	10-K
6	11-10-2022	09-30-2022	10-Q
7	08-09-2022	06-30-2022	10-Q
8	05-10-2022	03-31-2022	10-Q
9	03-18-2022	12-31-2021	10-K
10	11-09-2021	09-30-2021	10-Q
11	08-10-2021	06-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

A Glimpse Into The Expert Outlook On Janux...
04/16/2024 12:00:53

JonesTrading Initiates Coverage On Janux T...
04/16/2024 10:50:27

JonesTrading analyst Soumit Roy initiates coverage on Janux Therapeutics (NASDAQ:JANX) with a Buy rating and announces Price...

Why Fastenal Shares Are Trading Lower By A...
04/11/2024 17:33:07

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter f...

why-is-cancer-focused-janux-therapeutics-stock-trading-higher-on-thursday

Why Is Cancer-Focused Janux Therapeutics S...
04/11/2024 16:13:56

Janux Therapeutics may be up for sale amid interest from major pharmaceutical firms. With shares quadrupling this year and a su...

enliven-therapeutics-alpine-immune-sciences-janux-therapeutics-and-other-big-stocks-moving-higher-on-thursday

Enliven Therapeutics, Alpine Immune Scienc...
04/11/2024 14:01:51

U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday. Shares of Enliven Therapeutics, Inc. (NA...

Janux Therapeutics Shares Resume Trade Fol...
04/10/2024 17:48:38

"Drugmaker Janux Therapeutics Said To Weig...
04/10/2024 17:43:08

- Bloomberg

10-health-care-stocks-whale-activity-in-todays-session

10 Health Care Stocks Whale Activity In To...
04/04/2024 17:35:24

BTIG Initiates Coverage On Janux Therapeut...
03/21/2024 10:00:23

BTIG analyst Kaveri Pohlman initiates coverage on Janux Therapeutics (NASDAQ:JANX) with a Buy rating and announces Price Tar...

cancer-focused-janux-therapeutics-platform-has-tremendous-opportunity-analyst

Cancer-Focused Janux Therapeutics Platform...
03/20/2024 17:44:16

Cantor Fitzgerald's coverage on Janux Therapeutics and its TRACTr/TRACir platform targeting diverse tumor antigens and canc...

Forecasting The Future: 4 Analyst Projecti...
03/20/2024 14:00:54

Cantor Fitzgerald Initiates Coverage On Ja...
03/20/2024 09:24:21

Cantor Fitzgerald analyst Josh Schimmer initiates coverage on Janux Therapeutics (NASDAQ:JANX) with a Overweight rating and ...

B of A Securities Maintains Buy Rating for...
03/13/2024 17:00:15

B of A Securities Maintains Buy on Janux T...
03/13/2024 14:31:15

B of A Securities analyst Geoff Meacham maintains Janux Therapeutics (NASDAQ:JANX) with a Buy and raises the price target fr...

Why Asana Shares Are Trading Lower By 11%?...
03/12/2024 18:07:31

Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance.

HC Wainwright & Co. Maintains Buy on Janux...
03/11/2024 10:38:11

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Janux Therapeutics (NASDAQ:JANX) with a Buy and raises the ...

Janux Therapeutics Q4 EPS $(0.25) Beats $(...
03/08/2024 21:15:09

Janux Therapeutics (NASDAQ:JANX) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(...

Janux Therapeutics Prices $296.5M Underwri...
02/29/2024 07:06:55

Janux Therapeutics, Inc. (NASDAQ:JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel...

Janux Therapeutics Announces Proposed $175...
02/27/2024 22:50:35

Dow Dips Over 100 Points; J.M. Smucker Pos...
02/27/2024 19:32:26

U.S. stocks traded mixed toward the end of trading, with the Dow Jones index falling more than 100 points on Tuesday. The Dow ...